F superior high quality of the emberyo (n=34), twenty (58.8 ) were obese PCOS compare to 14 (41.two ) overweight PCOS. Also clinically pregnant was significantly elevated in obesePCOS as in comparison with overweight PCOS ones. AMH and androgens levels as regard to outcome of IVF/ICSI When authors compared the correlation amongst AMH, TT, A4 and DAHE-S among the outcome of IVF/ICSI relating to all investigated PCOS girls (n=195), AMH showed no important benefits using the outcome of IVF/ICSI, whilst TT, A4 and DAHES showed substantial correlation (p0.0001) with retrieved oocyte, fertilized and mature oocyst. Amongst the whole PCOS group, for over-weight PCOS females (n=104) important correlation was reported between TT, A4 and DAHES and retrieved oocyte, fertilized and mature oocyst (p0.0001), while AMH showed only considerable inverse correlation with fertilized oocyt (R=-0.469, p0.0001). When thinking of the obese PCOS, a substantial correlation was reported among TT, A4 and DAHE-S and fertilized and mature oocyst (R=0.322, 0.517 and 0.355, respectively at p0.0001), for AMH, a considerable correlation with mature oocyte (R=0.268, p=0.01) was detected. For obese PCOS females AMH revealed inverse important correlation with clinical pregnancy (R=-0.516, p0.0001) when TT and DAHES showed direct correlation (R=0.215, p=0.014, R=0.24, p=0.022, respectively). For overweight PCOS females, both TT and A4 showed inverse substantial correlation (R=0.201, p=0.04, R=-0.324, p=0.001, respectively). Amongst the entire groups, the levels of AMH and androgens for both obese PCOS and over-weight PCOS stratified by outcome of IVF/ICSI are shown in table IV. As authors were interested about PCOS girls created pregnancy (n=116), AMH and A4 have been substantially increased (p0.001) in pregnant obese PCOS women (three.6?.3, 3.two?.78, respectively) versus pregnant overweight PCOS girls (3.four?.three, 2.7?.8, respectively), although DAHES was drastically decreased (p0.001) in pregnant obese PCOS women (3.7?.7) versus pregnant overweight PCOS females (four.8?).Iranian Journal of Reproductive Medicine Vol. 11. No. 11. pp: 883-890, NovemberPredictability of AMH and androgens hormones in PCOS womenTable I. Traits features with the enrolled individualsVariable Age BMI FSH (IU/L) LH (IU/L) LH / FSH PRL (IU/L) E2 (IU/L) TSH (IU/L) AMH (ng/ml) TT (nmol/L) A4 (nmol/L) DAHE-S (?mol/L)\ Total oocyte retrieved Mature oocyte Fertilized oocyte Embryo quantity Clinical pregnancy Non-pregnant Pregnant PCOS (n=195) Imply ?SD 28.two ?3.7 27.67 ?four.two six.2 ?1.7 6.2 ?two 1.136992-21-7 web 09 ?0.Formula of 957135-12-5 four 13 ?five.PMID:27102143 three 42 ?16 two.two ?0.7 three.6 ?0.six 0.19 ?0.61 three.4 ?2.six 4.1 ?two 16.3 ?6.four 13 ?5 ten ?4 5? 79 116 95 CI 27.7-28.7 27-28.7 6-6.4 6-6.five 1-1.16 12.3-13.eight 39 2-2.three 3.5-3.7 0.16-0.two 3.1-3.9 three.8-4.four 15.3-17.two 12.2-13.six 9.4-10.six 4.6-5.Table II. Clinical and endocrine parameters among investigated groupsGroups Traits Age (years) FSH (IU/L) LH (IU/L) LH / FSH E2 (IU/L) PRL (IU/L) TSH (IU/L) Serum AMH (ng/ml) TT (nmol/L) A4 (nmol/L) DAHE-S (?mol/L) Statistical analysis using analysis of variance (ANOVA). Obese PCOS (n=91) 28.six ?4 6.59 ?1.6 six.1 ?1 1 ?0.3 38.five ?15 11.6 ?5.5 2.three ?0.6 three.9 ?0.four 0.18 ?0.two 4.2 ?three.7 3.four ?1.7 Over-weight PCOS (n=104) 27.8 ?3.six 5.89 ?1.eight six.three ?2.6 1.2 ?0.4 45 ?17 14.four ?four.9 2.1 ?0.9 three.3 ?0.6 0.19 ?0.1 three ?0.7 4.7 ?two p-value 0.153 0.006 0.512 0.005 0.006 0.0001 0.036 0.0001 0.968 0.0001 0.Table III. Traits of outcome of IVF/ICSI amongst the PCOS women regarding their obesityIVF/ICSI outcome Obese PCOS (n=91) Total oocyte retri.